May 2010 | OncologyLive

Well-done Meat Found to Increase Bladder Cancer Risk

June 02, 2010

According to a large study conducted at the University of Texas MD Anderson Cancer Center and presented at the AACR 101st Annual Meeting 2010, eating well-done meat, especially red meat, may increase the risk of bladder cancer, particularly in individuals with genetic variants in their metabolism.

Pre-clinical Study Suggests Nab-paclitaxel Plus Bevacizumab May hold Promise for Treating Triple Negative Breast Cancer

June 02, 2010

According to a pre-clinical study presented at the AACR 101st Annual Meeting 2010, a regimen of nab-paclitaxel (Abraxane) given in combination with bevacizumab (Avastin) may have potential in treating triple-negative breast cancer, one of the most aggressive, therapy- resistant, and highly metastatic subtypes of breast cancer.

NO-Naproxen May Protect Against Colorectal Cancer

June 02, 2010

A study presented at the AACR 101st Annual Meeting 2010 by researchers from the Fox Chase Cancer Center, Philadelphia, Pennsylvania, provides further evidence that non-steroidal anti-inflammatory drugs (NSAIDs) are promising chemopreventive agents with activity against colorectal cancer.

New Gene Technology Assesses Nine Genes that may Predict Response to Panitumumab

June 02, 2010

Although KRAS gene mutation is a well-established biomarker for a lack of response to anti-epidermal growth factor receptor (anti-EGFR) antibodies in colorectal cancer, a study presented at the AACR 101st Annual Meeting 2010 sought to determine whether mutations in 9 genes known to be mutated in colorectal cancer, including AKT1, BRAF, CTNNB1, EGFR, KRAS (exon 3), NRAS, PIK3CA, PTEN, and TP53, could also predict response to Vectibix (panitumumab) in patients with metastatic colorectal cancer.

Melanoma: Improving Clinical Outcomes Through Advances in Immunotherapeutics and Targeted Therapy

June 02, 2010

Metastatic melanoma has limited treatment options, but advances in the understanding of the oncogenic mutations that drive this cancer and how the immune system can be better modulated to fight melanoma provide a new generation of active approaches for patients.

Medication Adherence Technologies: Promise or Pitfalls?

June 02, 2010

Historically, most cancer treatments have been administered in oncology offices or hospitals, but oral medications are becoming increasingly common, and oral formulations of chemotherapy, targeted therapies, and hormonal therapies are available.

WebMD Health Exchange Seeks to Connect Patients

June 02, 2010

The explosive growth of mainstream social networking sites has encouraged the development of smaller, niche networks designed to connect patients who share a diagnosis; however, no one platform has established itself as a central health-networking hub.

Cancer fundraising gone too far?

June 02, 2010

Susan G. Komen for the Cure's partnership with KFC to raise funds and spread breast cancer awareness and educational messaging by selling chicken in specially designed pink buckets has generated considerable controversy, with some wondering what message this partnership is sending.